GENE ONLINE|News &
Opinion
Blog

2022-01-17| Special

Biotech Showcase 2022: Healing the Psyche with Psychedelia

by Eduardo Longoria
Share To
The Biotech Showcase 2022 began on January 10th and prominently featured a panel on the use of psychedelics in the treatment of psychological and central nervous system (CNS) disorders. Moderated by Walter Greenleaf; the four panelists discussed the use of MDMA, Psilocybin and LSD for a variety of disorders and  the obstacles involved in the endeavor.

It's free! Log in now to read

LATEST
Flagship-Backed ProFound Launches With $75 Million to Discover Human Proteins
2022-05-27
Janssen’s First Cell Therapy Gets Europe’s Approval for Multiple Myeloma
2022-05-27
Cell and Gene Therapy Landscape in Japan is Moving Beyond Oncology
2022-05-27
New Study Reveals Hope for Recovery of Patients with Spinal Cord Injury
2022-05-27
Laekna Therapeutics Announces Dosing of First Patients in the U.S. and China in Phase Ib/III Study of Afuresertib in Combination with Fulvestrant in HR+/HER2- Breast Cancer
2022-05-26
Stanford Touts Remote-Controllable CAR-T Cell Therapy
2022-05-26
Phenomix Launches The First Obesity Biobank Registry To Study Underling Phenotypes
2022-05-26
EVENT
2022-06-03
ASCO Annual Meeting
Online and on-side
2022-06-07
Digital RESI June
Online
2022-06-09
Medhospafrica
Africa
2022-06-13
BIO International Convention
San Diego, CA
2022-12-14
BIOHK2022
Hong Kong, China
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!